arrow
E

Elisenda Cortès-Saladelafont

Hospital Universitari Germans Trias i Pujol
H指数:17
被引数:770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypertryptophanemia Associated With a Novel TDO2 Deletion and FITM2 Variant in Two Siblings With Neurodevelopmental Disorder

与神经发育障碍相关的两同胞中的新型<i>TDO2</i>缺失和<i>FITM2</i>变异引起的色氨酸血症

2026-10-090
PRE
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency

酪氨酸羟化酶(TH)缺乏症的诊断与治疗共识指南

2025-11-100
OAAI
Understanding the Natural History and the Effects of Current Therapeutic Strategies on Urea Cycle Disorders: Insights from the UCD Spanish Registry

理解尿素循环障碍的自然史及当前治疗策略对其的影响:来自UCD西班牙登记研究的见解

2025-03-280
OA
Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia
2022-06-167
PRE
Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
2021-11-0310
OAAI
Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines
2021-09-2025
OAAI
The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective

新型冠状病毒肺炎大流行对先天性代谢错误的诊断和管理的影响: 全球视角

2020-11-0132
OAAI
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies (vol 15, 126, 2020)
2020-08-054
OAAI
DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia
2020-05-3021
OAAI
The ethical framework for performing research with rare inherited neurometabolic disease patients

对罕见的遗传性神经代谢疾病患者进行研究的伦理框架

2017-01-1613
OAAI
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders (vol 10, 164, 2015)
2016-11-030
OAAI
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders
2015-12-3019
OAAI